CytoDyn Inc.: 10-Q filed 2016-01-11
What CytoDyn Inc. reported in its quarterly report filed 2016-01-11 (fiscal Q2 2016): 23 published measures, 63 facts as tagged in accession 0001193125-16-426510.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2016-01-11
- Fiscal period
- fiscal Q2 2016
- Accession
- 0001193125-16-426510 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All CytoDyn Inc. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-11-30 | 6,561,429 | USD | |
| At 2015-05-31 | 4,679,261 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-11-30 | 9,270,282 | USD | |
| At 2015-05-31 | 15,371,777 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-11-30 | -2,708,853 | USD | |
| At 2015-05-31 | -10,692,516 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-11-30 | 3,252,470 | USD | |
| At 2015-05-31 | 1,050,060 | USD | |
| At 2014-11-30 | 2,376,543 | USD | |
| At 2014-05-31 | 4,886,122 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-09-01 to 2015-11-30 | -5,264,593 | USD | 91 |
| 2015-06-01 to 2015-11-30 | -14,159,607 | USD | 183 |
| 2014-09-01 to 2014-11-30 | -4,983,914 | USD | 91 |
| 2014-06-01 to 2014-11-30 | -8,363,434 | USD | 183 |
Capital expenditure payments
Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-06-01 to 2014-11-30 | 16,052 | USD | 183 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-11-30 | -85,681,909 | USD | |
| At 2015-05-31 | -71,522,302 | USD |
Income tax expense or benefit
Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-09-01 to 2015-11-30 | 0 | USD | 91 |
| 2015-06-01 to 2015-11-30 | 0 | USD | 183 |
| 2014-09-01 to 2014-11-30 | 0 | USD | 91 |
| 2014-06-01 to 2014-11-30 | 0 | USD | 183 |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-11-30 | 18,828 | USD | |
| At 2015-05-31 | 24,213 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-06-01 to 2015-11-30 | 590,661 | USD | 183 |
| 2014-06-01 to 2014-11-30 | 287,847 | USD | 183 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-09-01 to 2015-11-30 | -2,893,779 | USD | 91 |
| 2015-06-01 to 2015-11-30 | -9,551,259 | USD | 183 |
| 2014-09-01 to 2014-11-30 | -2,991,680 | USD | 91 |
| 2014-06-01 to 2014-11-30 | -5,946,264 | USD | 183 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-11-30 | 4,100,362 | USD | |
| At 2015-05-31 | 2,037,809 | USD |
Interest expense
Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-09-01 to 2015-11-30 | 2,371,025 | USD | 91 |
| 2015-06-01 to 2015-11-30 | 4,671,245 | USD | 183 |
| 2014-09-01 to 2014-11-30 | 1,187,215 | USD | 91 |
| 2014-06-01 to 2014-11-30 | 1,613,283 | USD | 183 |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-11-30 | 9,270,282 | USD | |
| At 2015-05-31 | 10,725,252 | USD |
Current accounts payable
Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-11-30 | 4,496,198 | USD | |
| At 2015-05-31 | 5,016,261 | USD |
Net finite-lived intangible assets
Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-11-30 | 2,406,250 | USD | |
| At 2015-05-31 | 2,581,250 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-09-01 to 2015-11-30 | 2,893,779 | USD | 91 |
| 2015-06-01 to 2015-11-30 | 9,551,259 | USD | 183 |
| 2014-09-01 to 2014-11-30 | 2,991,680 | USD | 91 |
| 2014-06-01 to 2014-11-30 | 5,946,264 | USD | 183 |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-09-01 to 2015-11-30 | 1,661,069 | USD | 91 |
| 2015-06-01 to 2015-11-30 | 6,970,309 | USD | 183 |
| 2014-09-01 to 2014-11-30 | 2,087,323 | USD | 91 |
| 2014-06-01 to 2014-11-30 | 4,150,467 | USD | 183 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-11-30 | 63,644,348 | shares | |
| At 2015-05-31 | 63,644,348 | shares |
Additional paid-in capital
Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-11-30 | 82,881,900 | USD | |
| At 2015-05-31 | 60,766,047 | USD |
Net intangible assets excluding goodwill
Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-11-30 | 2,442,239 | USD | |
| At 2015-05-31 | 2,617,239 | USD |
Pre-tax income or loss from continuing operations
Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-09-01 to 2015-11-30 | -5,264,593 | USD | 91 |
| 2015-06-01 to 2015-11-30 | -14,159,607 | USD | 183 |
| 2014-09-01 to 2014-11-30 | -4,983,914 | USD | 91 |
| 2014-06-01 to 2014-11-30 | -8,363,434 | USD | 183 |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-09-01 to 2015-11-30 | 880,697 | USD | 91 |
| 2015-06-01 to 2015-11-30 | 1,737,357 | USD | 183 |
| 2014-09-01 to 2014-11-30 | 660,367 | USD | 91 |
| 2014-06-01 to 2014-11-30 | 1,324,873 | USD | 183 |
Inspect the source
- Entity
- CytoDyn Inc. / CIK 0001175680
- Captured
- 2026-09-20T07:44:48.635Z
- SEC response SHA-256
ccd180f98f5bd324896d13ce785229f8b7185dbfcf88932cc316c9c53bdaba90
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001175680.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))